Literature DB >> 3651264

Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer. A radiologic and physiologic study.

K Mattson1, L R Holsti, H Poppius, O Korhola, S Stenman, L Tammilehto, M Salmo.   

Abstract

Radiographic signs of radiation pneumonitis and fibrosis were assessed and pulmonary function monitored in lung cancer patients after two different split-course radiation therapy schedules, one with a rest interval of 3 weeks and the other with a rest interval of 5 weeks, the total radiation dose being the same in both treatments (55 Gy/20 fractions/7 or 9 weeks). Post-mortem findings were analysed when available. Spirometric measurement of vital capacity, determination of diffusing capacity for carbon monoxide (DL) and alveolar volume with the single breath technique, and determination of regional distribution of lung perfusion by two different techniques, radiospirometry and gamma camera digital display following intravenous injection of 133Xe, were carried out before and at various times after the completion of irradiation. Of the physiologic parameters, only DL showed a significant decrease 6 as well as 9 months post-treatment (p less than 0.05). No difference between the two treatment schedules could be shown with regard to grade or time pattern of radiologic changes or decrease in DL. The findings suggest that measurement of DL may be of value in monitoring patients included in research protocols for radiation therapy of lung cancer as well as in selection of patients for this treatment.

Entities:  

Mesh:

Year:  1987        PMID: 3651264     DOI: 10.3109/02841868709091430

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  1 in total

1.  Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation.

Authors:  Isis W Gayed; Joe Chang; E Edmund Kim; Rodolfo Nuñez; Beth Chasen; H Helen Liu; Katsuhiro Kobayashi; Yujing Zhang; Zhongxing Liao; Salman Gohar; Melinda Jeter; Louise Henderson; William Erwin; Ritsuko Komaki
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.